- Home
- ESPR vs MFM Comparison
ESPR vs MFM Comparison
Compare ESPR & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- MFM
- Stock Information
- Founded
- ESPR 2008
- MFM 1986
- Country
- ESPR United States
- MFM United States
- Employees
- ESPR N/A
- MFM N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- MFM Finance Companies
- Sector
- ESPR Health Care
- MFM Finance
- Exchange
- ESPR Nasdaq
- MFM Nasdaq
- Market Cap
- ESPR 220.0M
- MFM 212.1M
- IPO Year
- ESPR 2013
- MFM N/A
- Fundamental
- Price
- ESPR $2.17
- MFM $5.12
- Analyst Decision
- ESPR Buy
- MFM
- Analyst Count
- ESPR 6
- MFM 0
- Target Price
- ESPR $6.50
- MFM N/A
- AVG Volume (30 Days)
- ESPR 5.2M
- MFM 108.1K
- Earning Date
- ESPR 08-05-2025
- MFM 01-01-0001
- Dividend Yield
- ESPR N/A
- MFM 4.08%
- EPS Growth
- ESPR N/A
- MFM N/A
- EPS
- ESPR N/A
- MFM 0.03
- Revenue
- ESPR $268,125,000.00
- MFM N/A
- Revenue This Year
- ESPR $6.10
- MFM N/A
- Revenue Next Year
- ESPR N/A
- MFM N/A
- P/E Ratio
- ESPR N/A
- MFM $176.67
- Revenue Growth
- ESPR N/A
- MFM N/A
- 52 Week Low
- ESPR $0.69
- MFM $4.37
- 52 Week High
- ESPR $3.94
- MFM $5.48
- Technical
- Relative Strength Index (RSI)
- ESPR 73.45
- MFM 49.82
- Support Level
- ESPR $2.00
- MFM $5.03
- Resistance Level
- ESPR $2.14
- MFM $5.24
- Average True Range (ATR)
- ESPR 0.15
- MFM 0.05
- MACD
- ESPR 0.02
- MFM -0.01
- Stochastic Oscillator
- ESPR 95.08
- MFM 40.67
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.